No matching results for ''
Tip: Try a valid symbol or a specific company name for relevant results
Canada Markets open in 21 mins
MARKETS LIVE BLOG
STOCK FUTURES HOLD ONTO GAINS AFTER FED DECISION
Start of Fed tapering "likely to have minimal market impact at this stage," says BlackRock
Genmab A/S (GMAB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 4:00PM EDT
142 reactions on $GMAB conversation
Sign in to post a message.
BAL will get approved.
The approval of the following From loncar:
Lately the news has been ADC palooza. $SGEN & $GMAB were just approved in cervical cancer.
Why is it falling right now though? I can't see any bad press or anything (will be buying the dip ofc)
We will see 100 this year!
Takeover rumours are increased
Down 4% extended hours, please keep staying low so I can buy more
Anyone know why the recent increase sp?
Hoping for this GMAB bounce intraday. Nice mention alongside a few cancer stocks today so I'm happy so far
My target price is 57 to 65 dollars in the short term. In the long term, the growth could be exponential.
Even Pipeline expanding. genmab is like a mutual find of biotech with over 20 candidates over 33 different indications
It look be just a matter of time until someone takes this company out. Great pipeline/no debt and plenty of cash on hand. Just hold and wait.
Looks like things are starting are starting to heat up. Horizon report on may 5th be interesting and seeing how the Tepezza sales are going. I have a feeling in 2 years this stock price will double as there is a lot coming down the pipeline just my gut from what I have been reading
Great pipeline and Darzalex Fast Pro off to a good start even during Covid. Can’t get a better pipeline and already in the black for a young US company- IPO wasn’t that long ago! Long and strong/ forget that sell side today!! Want to get the shares cheaper as the analysts wake up to a great company!!
Free Cash Flow increasing from 1.2 billions to over 6 billions DKK. That is almost 600% jump with further growth and recurring revenue ! This is a super growth stock. Stock price will jump.
When JNJ took out Actelion for $30 billion it had no earnings and paid $280 a share. Genmab has $250 million USD net income already and is valued at only 6 billion.Putting same price on Genmab would be $500
What is this ...GMAB gets FDA approval on an MS drug and no market reaction??? I just bought some... hoping for markets react positively....
Copenhagen, Denmark; January 15, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (U.S. FDA) has approved the use of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide, and dexamethasone (VCd) for the treatment of adult patients with newly diagnosed light-chain (AL) amyloidosis.
I listened to conference. Newest Darzulex indication just approved by FDA yesterday could double royalty income from JNJ in coming year
Highlights from RBC 2020 #biotech outlook
Top Ideas: $GILD $GMAB $SRPT $EXEL $ACAD $OVID $MOLN $ATNX $APRE $CLIN $APTO
Stolen from the twitterverse:
Genmab $GMAB Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
$GMAB was targeting 20-ish % and min DOR 6mo so targets met with 24% and 8.3mo.
dont know why this didnt move on the abbvie news.
Split shares because management feels undervalued
How CMHC could help you buy a $1.25M home
Yahoo Finance Canada Videos
BlackBerry net loss surges to US$144 million in Q2 as revenue drops 32 per cent
The Canadian Press
China Tells Evergrande to Avoid Near-Term Default on Bonds
© 2021 Verizon Media. All rights reserved.
About Our Ads